Chemokine receptors

Cytokine and Growth Factor Reviews

Volumn 12, Issue 4, 2001, Pages 313-335

  Horuk, Richard ^a  

^a BAYER AG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA CHEMOKINE; BETA CHEMOKINE; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR10; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR3; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CCR6; CHEMOKINE RECEPTOR CCR7; CHEMOKINE RECEPTOR CCR8; CHEMOKINE RECEPTOR CCR9; CHEMOKINE RECEPTOR CX3CR1; CHEMOKINE RECEPTOR CXCR3; CHEMOKINE RECEPTOR CXCR4; CHEMOKINE RECEPTOR CXCR5; CHEMOKINE RECEPTOR CXCR6; CHEMOKINE RECEPTOR XCR1; GAMMA CHEMOKINE; LIGAND; MELANOMA GROWTH STIMULATORY ACTIVITY FACTOR; STROMAL CELL DERIVED FACTOR 1; UNCLASSIFIED DRUG;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AMINO ACID SEQUENCE; ANIMAL; CHEMISTRY; HOST RESISTANCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOMODULATION; METABOLISM; MOLECULAR CLONING; MOLECULAR GENETICS; NONHUMAN; PATHOGENESIS; PHYSIOLOGY; REVIEW; SEQUENCE ALIGNMENT; UNINDEXED SEQUENCE;

AMINO ACID SEQUENCE; ANIMALS; CHEMOKINES, C; CHEMOKINES, CC; CHEMOKINES, CXC; HUMANS; MOLECULAR SEQUENCE DATA; RECEPTORS, CHEMOKINE; SEQUENCE ALIGNMENT;

AIDS VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0034849509     PISSN: 13596101     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1359-6101(01)00014-4     Document Type: Review

References (198)

1. GPCRDB: An information system for G protein-coupled receptors
2. Molecular cloning, functional expression, and signaling characteristics of a C-C chemokine receptor
3. Chemokines-chemotactic cytokines that mediate inflammation
4. A receptor for the malarial parasite Plasmodium vivax: The erythrocyte chemokine receptor
5. Cloning and characterization of a novel promiscuous human beta-chemokine receptor D6
6. The interleukin-8-receptor family: From chemokines to malaria
7. Chemokines and HIV-1 second receptors - Confluence of two fields generates optimism in AIDS research
8. Molecular piracy of mammalian interleukin-8 receptor type B by herpesvirus saimiri
9. G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator
10. Chemokines and leukocyte traffic
11. A non-peptide functional antagonist of the CCR1 chemokine receptor is effective in rat heart transplant rejection
12. Identification of the binding site for a novel class of CCR2b chemokine receptor antagonists. Binding to a common chemokine receptor motif within the helical bundle
13. A small molecule antagonist of chemokine receptors CCR1 and CCR3. Potent inhibition of eosinophil function and CCR3-mediated HIV-1 entry
14. Identification of a potent, selective non-peptide CXCR2 antagonist that inhibits interleukin-8-induced neutrophil migration
15. The chemokines
16. The human N-formylpeptide receptor. Characterization of two cDNA isolates and evidence for a new subfamily of G-protein-coupled receptors
17. The chemotactic receptor for human C5a anaphylatoxin
18. Structure and functional expression of a human interleukin-8 receptor
19. Cloning of complementary DNA encoding a functional human interleukin-8 receptor
20. Structure and functional expression of the human macrophage inflammatory protein 1α/Rantes receptor
21. Monocyte chemotactic protein-2 (MCP-2) uses CCR1 and CCR2B as its functional receptors
22. Characterization of functional chemokine receptors (CCR1 and CCR2) on EoL-3 cells: A model system to examine the role of chemokines in cell function
23. Characterisation of macrophage inflammatory protein-5 human CC cytokine-2, a member of the macrophage-inflammatory-protein family of chemokines
24. Characterization of CKbeta8 and CKbeta8-1: Two alternatively spliced forms of human beta-chemokine, chemoattractants for neutrophils, monocytes, and lymphocytes, and potent agonists at CC chemokine receptor 1
25. HCC-2, a human chemokine: Gene structure, expression pattern, and biological activity
26. Molecular cloning of leukotactin1: A novel human beta-chemokine, a chemoattractant for neutrophils, monocytes, and lymphocytes, and a potent agonist at CC chemokine receptors 1 and 3
27. Preparation of specific polyclonal antibodies to a C-C chemokine receptor, CCR1, and determination of CCR1 expression on various types of leukocytes
28. Impaired host defense, hematopoiesis, granulomatous inflammation and type 1-type 2 cytokine balance in mice lacking CC chemokine receptor 1
29. Receptor expression and responsiveness of human dendritic cells to a defined set of CC and CXC chemokines
30. The CC chemokine antagonist Met-RANTES inhibits eosinophil effector functions through the chemokine receptors CCR1 and CCR3
31. Cloning and differential tissue-specific expression of three mouse{beta} chemokine receptor-like genes, including the gene for a functional macrophage inflammatory protein-1 {alpha} receptor
32. Targeted disruption of the β-chemokine receptor CCR1 protects against pancreatitis-associated lung injury
33. Targeting of the chemokine receptor CCR1 suppresses development of acute and chronic cardiac allograft rejection
34. Leukocyte recruitment during onset of experimental allergic encephalomyelitis is CCR1 dependent
35. Identification and characterization of small molecule functional antagonists of the CCR1 chemokine receptor
36. Identification and characterization of a potent, selective, and orally active antagonist of the CC chemokine receptor-1
37. Molecular cloning and functional expression of two monocyte chemoattractant protein 1 receptors reveals alternative splicing of the carboxyl-termina 1 tails
38. Characterization of the CCR2 chemokine receptor: Functional CCR2 receptor expression in B cells
39. Chemokine receptor responses on T cells are achieved through regulation of both receptor expression and signaling
40. Discovery and characterization of low molecular weight antagonists of the receptor for the chemokine MCP-1
41. The synthesis and biological evaluation of potent MCP-1 inhibitors
42. Molecular cloning and functional expression of murine JE (monocyte chemoattractant protein 1) and murine macrophage inflammatory protein la receptors-Evidence for two closely linked C-C chemokine receptors on chromosome 9
43. Chemokine receptor expression in cultured glia and rat experimental allergic encephalomyelitis
44. Cloning and functional expression of mCCR2, a murine receptor for the C-C chemokines JE and FIC
45. Species-specificity of monocyte chemotactic protein-1 and -3
46. Acute and relapsing experimental autoimmune encephalomyelitis are regulated by differential expression of the CC chemokines macrophage inflammatory protein-1alpha and monocyte chemotactic protein-1
47. CC chemokine receptor 2 is critical for induction of experimental autoimmune encephalomyelitis
48. Resistance to experimental autoimmune encephalomyelitis in mice lacking the CC chemokine receptor (CCR)2
49. Decreased lesion formation in CCR2 -/- mice reveals a role for chemokines in the initiation of atherosclerosis
50. Absence of CC chemokine receptor-2 reduces atherosclerosis in apolipoprotein E-deficient mice
51. Severe reduction in leukocyte adhesion and monocyte extravasation in mice deficient in CC chemokine receptor 2
52. Cloning and functional expression of a human eosinophil CC chemokine receptor
53. Cloning and expression of a human eosinophil CC chemokine receptor
54. Cloning, expression, and characterization of the human eosinophil eotaxin receptor
55. Cloning of the human eosinophil chemoattractant, eotaxin
56. Eotaxin-2 activates chemotaxis-related events and release of reactive oxygen species via pertussis toxin-sensitive G proteins in human eosinophils
57. Human monocyte chemoattractant protein (MCP)-4 is a novel CC chemokine with activities on monocytes, eosinophils, and basophils induced in allergic and nonallergic inflammation that signals through the CC chemokine receptors (CCR)-2 and -3
58. HIV-1 Tat protein mimicry of chemokines
59. A novel human CC chemokine, eotaxin-3, which is expressed in IL-4-stimulated vascular endothelial cells, exhibits potent activity toward eosinophils
60. Chemokine receptor usage by human eosinophils - The importance of CCR3 demonstrated using an antagonistic monoclonal antibody
61. The β-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates
62. A dual-tropic primary HIV-1 isolate that uses fusin and the β-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors
63. CCR3 and CCR5 are co-receptors for HIV-1 infection of microglia
64. Dendritic cells express multiple chemokine receptors used as coreceptors for HIV entry
65. Angiogenic and HIV-inhibitory functions of KSHV-encoded chemokines
66. Targeted disruption of the chemokine eotaxin partially reduces antigen-induced tissue eosinophilia
67. Antigen-induced eosinophilic lung inflammation develops in mice deficient in chemokine eotaxin
68. Molecular cloning and functional expression of a novel CC chemokine receptor cDNA from a human basophilic cell line
69. The T cell-directed CC chemokine TARC is a highly specific biological ligand for CC chemokine receptor 4
70. Macrophage-derived chemokine is a functional ligand for the CC chemokine receptor 4
71. Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s
72. Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes
73. The chemokine receptor CCR4 in vascular recognition by cutaneous but not intestinal memory T cells
74. Pivotal role of TARC, a CC chemokine, in bacteria-induced fulminant hepatic failure in mice
75. Molecular cloning and functional expression of a new human CC-chemokine receptor gene
76. Cloning and functional expression of CC CKR5, a human monocyte CC chemokine receptor selective for MIP-1α, MIP-1β, and RANTES
77. Identification of RANTES, MIP-1α, and MIP-1β as the major HIV-suppressive factors produced by CD8+ T cells
78. Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: Progression of disease is associated with a shift from monocytotropic to T-cell-tropic virus population
79. Increased viral burden and cytopathicity correlate temporally with CD4+ T-lymphocyte decline and clinical progression in human immunodeficiency virus type 1-infected individuals
80. Viral phenotype and immune response in primary human immunodeficiency virus type 1 infection
81. Differential syncytium-inducing capacity of human immunodeficiency virus isolates: Frequent detection of syncytium-inducing isolates in patients with acquired immunodeficiency virus syndrome (AIDS) and AIDS-related complex
82. Evidence for a role of virulent human immunodeficiency virus (HIV) variants in the pathogenesis of acquired immunodeficiency virus syndrome: Studies on sequential isolates
83. HIV-1 entry cofactor: Functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor
84. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection
85. Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene
86. Hemophilia growth and development study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study, and S.J. O'Brien, S.J., genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene
87. Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC), ALIVE Study, and O'Brien, S.J., contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression
88. Extension of recombinant human RANTES by the retention of the initiating methionine produces a potent antagonist
89. Potent inhibition of HIV-1 infectivity in macrophages and lymphocytes by a novel CCR5 antagonist
90. Phenotypic knockout of HIV type 1 chemokine coreceptor CCR-5 by intrakines as potential therapeutic approach for HIV-1 infection
91. Chemokines regulate hippocampal neuronal signaling and gp120 neurotoxicity
92. Signal transduction due to HIV-1 envelope interactions with chemokine receptors CXCR4 or CCR5
93. A small-molecule, nonpeptide CCR5 antagonist with highly potent and selective anti-HIV-1 activity
94. Human immunodeficiency virus-1 entry into purified blood dendritic cells through CC and CXC chemokine coreceptors
95. Polarization of chemokine receptors to the leading edge during lymphocyte chemotaxis
96. The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions
97. Chemokine receptor expression on resident and inflammatory cells in the brain of macaques with simian immunodeficiency virus encephalitis
98. Association of rheumatoid arthritis with a functional chemokine receptor, CCR5
99. Identification of CCR6, the specific receptor for a novel lymphocyte-directed CC chemokine LARC
100. Cloning of STRL22, a new human gene encoding a G-protein-coupled receptor related to chemokine receptors and located on chromosome 6q27
101. Molecular cloning, functional characterization and mRNA expression analysis of the murine chemokine receptor CCR6 and its specific ligand MIP-3α
102. Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites
103. Up-regulation of macrophage inflammatory protein-3alpha/CCL20 and CC chemokine receptor 6 in psoriasis
104. Chemokines and the homing of dendritic cells to the T cell areas of lymphoid organs
105. Molecular cloning of a novel human CC chemokine EBI1-ligand chemokine that is a specific functional ligand for EBI1, CCR7
106. Secondary lymphoid-tissue chemokine is a functional ligand for the CC chemokine receptor CCR7
107. 6-C-kine (SLC), a lymphocyte adhesion-triggering chemokine expressed by high endothelium, is an agonist for the MIP-3β receptor CCR7
108. CCR7 ligands, SLC/6Ckine/Exodus2/TCA4 and CKbeta-11/MIP-3beta/ELC, are chemoattractants for CD56(+)CD16(-) NK cells and late stage lymphoid progenitors
109. Cloning of human and mouse EBI1, a lymphoid-specific G-protein-coupled receptor encoded on human chromosome 17q12-q21.2
110. EBI1-ligand chemokine (ELC) attracts a broad spectrum of lymphocytes: Activated T cells strongly up-regulate CCR7 and efficiently migrate toward ELC
111. Enhanced HIV-1 replication by chemokines constitutively expressed in secondary lymphoid tissues
112. Identification of CCR8: A human monocyte and thymus receptor for the CC chemokine I-309
113. Identification of CCR8, the receptor for the human CC chemokine I-309
114. The CC chemokine I-309 inhibits CCR8-dependent infection by diverse HIV-1 strains
115. Identification of CCR8 as the specific receptor for the human beta-chemokine I-309: Cloning and molecular characterization of murine CCR8 as the receptor for TCA-3
116. Molecular cloning of TER1, a chemokine receptor-like gene expressed by lymphoid tissues
117. The chemokine receptor CCR8 is preferentially expressed in Th2 but not Th1 cells
118. HHV8-encoded vMIP-I selectively engages chemokine receptor CCR8. Agonist and antagonist profiles of viral chemokines
119. A highly selective CC chemokine receptor (CCR)8 antagonist encoded by the poxvirus Molluscum contagiosum
120. Identification of the orphan chemokine receptor GPR-9-6 as CCR9, the receptor for the chemokine TECK
121. Lymphocyte CC chemokine receptor 9 and epithelial thymus-expressed chemokine (TECK) expression distinguish the small intestinal immune compartment, epithelial expression of tissue-specific chemokines as an organizing principle in regional immunity
122. Chemokines: A new classification system and their role in immunity
123. Cutting edge: The orphan chemokine receptor G protein-coupled receptor-2 (GPR-2, CCR10) binds the skin-associated chemokine CCL27 (CTACK/ALP/ILC)
124. Cutting edge: Identification of the orphan receptor G-protein-coupled receptor 2 as CCR10, a specific receptor for the chemokine ESkine
125. Cutting edge: A novel chemokine ligand for CCR10 and CCR3 expressed by epithelial cells in mucosal tissues
126. CCR11 is a functional receptor for the monocyte chemoattractant protein family of chemokines
127. Cutting edge: Identification of a novel chemokine receptor that binds dendritic cell- and T cell-active chemokines including ELC, SLC, and TECK
128. CCR11 is a functional receptor for the monocyte chemoattractant protein family of chemokines
129. Characterization of a receptor for human monocyte-derived neutrophil chemotactic factor/interleukin-8
130. Neutrophil-activating peptide 2 and gro/melanoma growth-stimulatory activity interact with neutrophil-activating peptide 1/interleukin 8 receptors on human neutrophils
131. Identification and characterization of a specific receptor for monocyte-derived neutrophil chemotactic factor (MDNCF) on human neutrophils
132. Model systems for the study of seven transmembrane-segment receptors
133. Characterization of two high affinity human interleukin-8 receptors
134. Assignment of the genes encoding human interleukin-8 receptor types 1 and 2 and an interleukin-8 receptor pseudogene to chromosome 2q35
135. Melanoma growth-stimulatory activity/GRO decreases collagen expression by human fibroblasts. Regulation by C-X-C but not C-C cytokines
136. Expression of transcripts for two interleukin 8 receptors in human phagocytes, lymphocytes and melanoma cells
137. Expression of chemokine receptors by subsets of neurons in the normal central nervous system
138. CD4-independent association between HIV-1 gp120 and CXCR4: Functional chemokine receptors are expressed in human neurons
139. Interleukin-8 receptor B immunoreactivity in brain and neuritic plaques of Alzheimer's disease
140. Patterns of aberrant sprouting in Alzheimer's disease
141. Re-evaluation of the structural organization of neuritic plaques in Alzheimer's disease
142. Localization of amyloid precursor protein in GAP43-immunoreactive aberrant sprouting neurites in Alzheimer's disease
143. GAP-43 as a marker for structural plasticity in the mature CNS
144. The expression of GAP-43 in relation to neuronal growth and plasticity: When, where, how, and why?
145. Trophic effects of interleukin-4, -7 and -8 on hippocampal neuronal cultures: Potential involvement of glial-derived factors
146. Production of hemolymphopoietic cytokines (IL-6, IL-8, colony-stimulating factors) by normal human astrocytes in response to IL-1 beta and tumor necrosis factor-alpha
147. Upregulation of interleukin 8 by oxygen-deprived cells in glioblastoma suggests a role in leukocyte activation, chemotaxis, and angiogenesis
148. Neutrophil and B cell expansion in mice that lack the murine IL-8 receptor homolog
149. Neutrophilia in mice that lack the murine IL-8 receptor homolog - Response
150. Amino terminus of the interleukin-8 receptor is a major determinant of receptor subtype specificity
151. Partial functional mapping of the human interleukin-8 type A receptor. Identification of a major ligand binding domain
152. Cloning and chromosomal mapping of three novel genes, GPR9, GPR10, and GPR14 encoding receptors related to interleukin 8, neuropeptide Y, and somatostatin receptors
153. Chemokine receptor specific for IP10 and Mig: Structure, function, and expression in activated T-lymphocytes
154. Interferon-inducible T cell alpha chemoattractant (I-TAC): A novel non-ELR CXC chemokine with potent activity on activated T cells through selective high affinity binding to CXCR3
155. Requirement of the chemokine receptor CXCR3 for acute allograft rejection
156. Molecular cloning of cDNAs encoding a LD78 receptor and putative leukocyte chemotactic peptide receptors
157. Molecular cloning of the cDNA and chromosomal localization of the gene for a putative seven-transmembrane segment (7-TMS) receptor isolated from human spleen
158. A proposed bovine neuropeptide Y (NPY) receptor cDNA clone, or its human homologue, confers neither NPY binding sites nor NPY responsiveness on transfected cells
159. Molecular cloning, characterization, and localization of the human homolog to the reported bovine NPY Y3 receptor: Lack of NPY binding and activation
160. Cloning of a human seven-transmembrane domain receptor, LESTR, that is highly expressed in leukocytes
161. The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry
162. The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1
163. The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes
164. Chemokine receptors in human endothelial cells. Functional expression of CXCR4 and its transcriptional regulation by inflammatory cytokines
165. Defects of B-cell lymphopoiesis and bone marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1
166. Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development
167. The chemokine receptor CXCR4 is essential for the vascularization of the gastrointestinal tract
168. Neuronal apoptosis induced by HIV-1 gp120 and the chemokine SDF-1α is mediated by the chemokine receptor CXCR4
169. The HIV-1 envelope protein gp120 induces neuronal apoptosis in hippocampal slices
170. HIV-1 gp120 produces DNA fragmentation in the cerebral cortex of rat
171. A small molecule CXCR4 inhibitor that blocks T cell line-tropic HIV-1 infection
172. A small-molecule inhibitor directed against the chemokine receptor CXCR4 prevents its use as an HIV-1 coreceptor
173. Inhibition of T-tropic HIV strains by selective antagonization of the chemokine receptor CXCR4
174. Structure-activity relationships of an anti-HIV peptide, T22
175. HIV coreceptor downregulation as antiviral principle: SDF-1α-dependent internalization of the chemokine receptor CXCR4 contributes to inhibition of HIV replication
176. Inactivation of HIV-1 chemokine co-receptor CXCR-4 by a novel intrakine strategy
177. A C-terminal signal prevents secretion of luminal ER proteins
178. B cell-attracting chemokine 1, a human CXC chemokine expressed in lymphoid tissues, selectively attracts B lymphocytes via BLR1/CXCR5
179. Differentiation-specific expression of a novel G protein-coupled receptor from Burkitt's lymphoma
180. Selective expression of the murine homologue of the G-protein-coupled receptor BLR1 in B cell differentiation, B cell neoplasia and defined areas of the cerebellum
181. A putative chemokine receptor, BLR1, directs B cell migration to defined lymphoid organs and specific anatomic compartments of the spleen
182. Abnormal expression of the B-cell homing chemokine receptor BLR1 during the progression of acquired immunodeficiency syndrome
183. Expression of the G-protein-coupled receptor BLR1 defines mature, recirculating B cells and a subset of T-helper memory cells
184. A transmembrane CXC chemokine is a ligand for HIV-coreceptor Bonzo
185. Identification of CX3CR1. A chemotactic receptor for the human CX3C chemokine fractalkine and a fusion coreceptor for HIV-1
186. Role for neuronally derived fractalkine in mediating interactions between neurons and CX3CR1-expressing microglia
187. In vivo inhibition of CC and CX3C chemokine-induced leukocyte infiltration and attenuation of glomerulonephritis in Wistar-Kyoto (WKY) rats by vMIP-II
188. Expression of CX3CR1 chemokine receptors on neurons and their role in neuronal survival
189. Prevention of crescentic glomerulonephritis by immunoneutralization of the fractalkine receptor CX3CR1 rapid communication
190. Identification of single C motif-1/lymphotactin receptor XCR1